drugset / Press release

新聞專區-全球創新藥「速必一」(ON101) 國際多中心三期臨床試驗結果與藥物作用機制刊載於JAMA Network Open由多國媒體報導露出

2021-11-26 · Oneness Biotech Co., Ltd. · original onenessbio.com ↗

發布日期: 2021-11-26 原始連結: https://www.onenessbio.com/tc/news_detail39_1.htm Diabetes Self-Management: New Cream Cures Foot Ulcers Diabetes Self-Management: New Topical Drug Helps Foot Ulcers Heal in Clinical Trial 猫薬プロジェクト3rd〜ある薬剤師の備忘録: 糖尿病性足潰瘍患者の創傷治癒に対する新規マクロファージ制御薬の効果はどのくらい? 科研星球: JAMA丨全球首个!糖尿病足溃疡新药:研发代号「ON101」 MedNews press: РАСТИТЕЛЬНЫЙ КРЕМ ДЛЯ ЛЕЧЕНИЯ ДИАБЕТИЧЕСКИХ ЯЗВ ПРЕВЗОШЕЛ АБСОРБИРУЮЩИЕ ПОВЯЗКИ germanic: Neuartige diabetische Fußulkus-Creme verspricht Versprechen in Phase-3-Studie e-Med: תכשיר לוויסות פעילות המקרופאגים עשוי לסייע בטיפול ברגל סוכרתית (JAMA Network Open) Espanol News: LA NUEVA CREMA PARA ÚLCERAS DEL PIE DIABÉTICO ES PROMETEDORA EN EL ENSAYO DE FASE 3 Les Actualites: UNE NOUVELLE CRÈME CONTRE L’ULCÈRE DU PIED DIABÉTIQUE EST PROMETTEUSE DANS L’ESSAI DE PHASE 3 MedicalTribune: N糖尿病性足潰瘍に新規MΦ調節薬が有望 完全治癒はドレッシング材の2.84倍 醫脈通: 足溃疡治疗新药——ON101的3期临床研究结果揭晓 Medscape: Novel Diabetic Foot Ulcer Cream Shows Promise in Phase 3 Trial 2 minute medicine: Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing Bio Space: A novel macrophage-regulating new drug has shown promise in treating diabetic foot ulcers according to the latest issue of article published by the JAMA Network Open Medical Dialogues: Topical Application Of Novel Drug Improved Healing In Patients With Diabetic Foot Ulcers: JAMA 唯信-鄭老師: 台湾试验了一个新药,对糖尿病足有明显效果! 这篇JAMA论文设计方案值得学习 MEDPAGETODAY: Topical Cream Effective Against Diabetic Foot Ulcers — Investigational compound regulates macrophages, is “active-healing alternative,” researchers say 藥時代: 重磅!全球首创糖尿病足新药速必一(ON101)在权威期刊JAMA发表重要结果

The release as fetched from its publisher. onenessbio.com ↗